RGS2 and Huntington disease: Second, miR-22 is predicted to target Rgs2; we have recently shown that decreased Rgs2 expression in striatal neurons is protective in in vitro models of HD by decreasing extracellular-signal-regulated kinase (ERK) activation [12].